Zoetis ZTS
NYSE ZTS
$84.39 +0.57 (+0.68%)
At close: Nov 16, 2026 · 4:00 PM EST

Zoetis (ZTS) Liabilities from Discontinued Operations (2015 - 2024)

Updated

Zoetis (ZTS) reported Liabilities from Discontinued Operations of $26 million for Q3 2024, up 4.0% from the prior quarter.

Analysis

Zoetis (ZTS) Liabilities from Discontinued Operations (2015 - 2024) Analysis & Trends

At the end of FY2015, Zoetis posted Liabilities from Discontinued Operations of $4 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Zoetis 34.65 Bn 27.05 Bn 1.69 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 26.00 Mn
Jun 30, 2024 25.00 Mn
Oct 1, 2017 6.00 Mn
Jul 2, 2017 4.00 Mn
Apr 3, 2016 4.00 Mn
Dec 31, 2015 4.00 Mn
API Access

Zoetis Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=ZTS&period=max&api_key=YOUR_API_KEY